What this means
Researchers plan to give a plant extract by mouth to healthy adults and watch for side effects. This study is still recruiting, so no results are available yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 55–65
- Where
- 1 site
The science
- Registered title
- Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient
- Trial ID
- NCT05936346 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Aging
- What is tested
- Salvia haenkei 175mg, Salvia haenkei 350mg
- Sponsor
- IBSA Farmaceutici Italia Srl
- Ages
- 55 Years to 65 Years
- Dates
- First posted Jul 7, 2023 · updated Jan 23, 2025
Registry summary
Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.
Sites (1)
- Ospedale Regionale di Lugano, Lugano, Switzerland